Thymulin
Thymulin (Zinc-Bound Nonapeptide)
Thymulin is a zinc-dependent nonapeptide hormone (Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) produced exclusively by the thymic epithelial cells that plays a critical role in T-cell differentiation and maturation. It is used primarily in research contexts for its immunomodulatory properties, with emerging interest in age-related immune decline (immunosenescence), autoimmune conditions, and inflammatory disorders. Thymulin activity is strictly dependent on bound zinc; without zinc, the peptide is biologically inactive.
Mechanism of Action
Thymulin binds to specific receptors on immature T-lymphocytes (thymocytes), promoting their differentiation into functionally competent CD4+ and CD8+ T-cells and inducing expression of T-cell surface markers. It modulates cytokine signaling by suppressing pro-inflammatory mediators such as TNF-α and IL-1β while upregulating regulatory T-cell activity, contributing to immune tolerance. Its activity requires stoichiometric zinc binding, which induces the conformational change necessary for receptor recognition; zinc deficiency therefore directly impairs thymulin-mediated immune regulation.
Evidence by Health Goal(15 goals)
Dosing Protocols
Morning, on empty stomach or at least 2 hours post-meal
Cycle: 8 weeks on, 4 weeks off
Administered subcutaneously. Reconstitute lyophilized powder with bacteriostatic water. Ensure adequate zinc status before use (supplement with 15-30mg elemental zinc daily if needed). Research dosing only; no approved clinical dosing exists.
Morning upon waking
Cycle: 8 weeks on, 4 weeks off
Nasal administration is used in some research and compounding pharmacy formulations. Bioavailability via this route is lower and less well-characterized than subcutaneous injection; dose is adjusted upward accordingly. Zinc supplementation still recommended concurrently.
Safety & Side Effects
Thymulin has a generally favorable safety profile in short-term research studies with no significant toxicity reported at research-grade doses, but long-term safety data in humans is very limited and it remains an investigational compound with no regulatory approval for therapeutic use. Individuals with active autoimmune disease, organ transplants, or those on immunosuppressive therapy should not use thymulin without medical supervision, as immune potentiation may worsen their condition.
Possible Side Effects
- !Mild injection site redness or irritation (subcutaneous administration)
- !Transient fatigue or flu-like malaise following initial doses
- !Nasal irritation or mild congestion with intranasal administration
- !Transient hypersensitivity reactions including urticaria in rare cases
- !Potential over-activation of immune response exacerbating autoimmune symptoms at high doses
- !Headache reported in some subjects during initial treatment period
- !Theoretical risk of immune dysregulation with prolonged unsupervised use
Interactions
- -May antagonize immunosuppressive drugs (cyclosporine, tacrolimus, corticosteroids) by counteracting T-cell suppression
- -Concurrent zinc supplementation enhances activity; excessive zinc (>150mg/day) may paradoxically impair immune function
- -Additive immunomodulatory effects possible when combined with other thymic peptides (Thymosin Alpha-1, Thymosin Beta-4) - monitor for immune overstimulation
- -May reduce efficacy of chemotherapy agents reliant on immune suppression; avoid concurrent use in oncology settings without oversight
- -Zinc-chelating agents (e.g., EDTA, high-dose iron supplementation) may inactivate thymulin by displacing bound zinc
Cost & Where to Buy
Thymulin is available from research peptide vendors in lyophilized form; pricing varies significantly by vendor purity, quantity purchased, and vial concentration. Nasal formulations from compounding pharmacies are typically more expensive. Zinc supplementation adds a minor additional cost.
Search on Amazon